351 related articles for article (PubMed ID: 15094120)
1. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion.
Bellail AC; Hunter SB; Brat DJ; Tan C; Van Meir EG
Int J Biochem Cell Biol; 2004 Jun; 36(6):1046-69. PubMed ID: 15094120
[TBL] [Abstract][Full Text] [Related]
2. Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma.
Kim Y; Kang H; Powathil G; Kim H; Trucu D; Lee W; Lawler S; Chaplain M
PLoS One; 2018; 13(10):e0204865. PubMed ID: 30286133
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of invasion and motility of high-grade gliomas in the brain.
Mair DB; Ames HM; Li R
Mol Biol Cell; 2018 Oct; 29(21):2509-2515. PubMed ID: 30325290
[TBL] [Abstract][Full Text] [Related]
4. A liquid fraction of extracellular matrix inhibits glioma cell viability
Murdock MH; Hussey GS; Chang JT; Hill RC; Nascari DG; Rao AV; Hansen KC; Foley LM; Hitchens TK; Amankulor NM; Badylak SF
Oncotarget; 2022; 13():426-438. PubMed ID: 35198102
[TBL] [Abstract][Full Text] [Related]
5. Live Mapping of the Brain Extracellular Matrix and Remodeling in Neurological Disorders.
Ge X; Xu X; Cai Q; Xiong H; Xie C; Hong Y; Gao X; Yao Y; Bachoo R; Qin Z
Small Methods; 2024 Jan; 8(1):e2301117. PubMed ID: 37922523
[TBL] [Abstract][Full Text] [Related]
6. Spatial heterogeneity in tumor adhesion qualifies collective cell invasion.
Sai Prasanna CV; Jolly MK; Bhat R
Biophys J; 2024 May; ():. PubMed ID: 38725244
[TBL] [Abstract][Full Text] [Related]
7.
Civita P; Valerio O; Naccarato AG; Gumbleton M; Pilkington GJ
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322379
[TBL] [Abstract][Full Text] [Related]
8. Compression stiffening of brain and its effect on mechanosensing by glioma cells.
Pogoda K; Chin L; Georges PC; Byfield FJ; Bucki R; Kim R; Weaver M; Wells RG; Marcinkiewicz C; Janmey PA
New J Phys; 2014 Jul; 16():075002. PubMed ID: 25844043
[TBL] [Abstract][Full Text] [Related]
9. A neurocentric perspective on glioma invasion.
Cuddapah VA; Robel S; Watkins S; Sontheimer H
Nat Rev Neurosci; 2014 Jul; 15(7):455-65. PubMed ID: 24946761
[TBL] [Abstract][Full Text] [Related]
10. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Verhaak RG; Hoadley KA; Purdom E; Wang V; Qi Y; Wilkerson MD; Miller CR; Ding L; Golub T; Mesirov JP; Alexe G; Lawrence M; O'Kelly M; Tamayo P; Weir BA; Gabriel S; Winckler W; Gupta S; Jakkula L; Feiler HS; Hodgson JG; James CD; Sarkaria JN; Brennan C; Kahn A; Spellman PT; Wilson RK; Speed TP; Gray JW; Meyerson M; Getz G; Perou CM; Hayes DN;
Cancer Cell; 2010 Jan; 17(1):98-110. PubMed ID: 20129251
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
Cancer Genome Atlas Research Network
Nature; 2008 Oct; 455(7216):1061-8. PubMed ID: 18772890
[TBL] [Abstract][Full Text] [Related]
12. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.
Phillips HS; Kharbanda S; Chen R; Forrest WF; Soriano RH; Wu TD; Misra A; Nigro JM; Colman H; Soroceanu L; Williams PM; Modrusan Z; Feuerstein BG; Aldape K
Cancer Cell; 2006 Mar; 9(3):157-73. PubMed ID: 16530701
[TBL] [Abstract][Full Text] [Related]
13. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
Wang C; Tong X; Yang F
Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
[TBL] [Abstract][Full Text] [Related]
14. Role of tenascins in the ECM of gliomas.
Brösicke N; Faissner A
Cell Adh Migr; 2015; 9(1-2):131-40. PubMed ID: 25695402
[TBL] [Abstract][Full Text] [Related]
15. Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix-associated gene modules.
Balvers RK; Kleijn A; Kloezeman JJ; French PJ; Kremer A; van den Bent MJ; Dirven CM; Leenstra S; Lamfers ML
Neuro Oncol; 2013 Dec; 15(12):1684-95. PubMed ID: 24046260
[TBL] [Abstract][Full Text] [Related]
16. Modulation of hyaluronan production by CD44 positive glioma cells.
Wiranowska M; Ladd S; Moscinski LC; Hill B; Haller E; Mikecz K; Plaas A
Int J Cancer; 2010 Aug; 127(3):532-42. PubMed ID: 19957333
[TBL] [Abstract][Full Text] [Related]
17. The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells.
Ulrich TA; de Juan Pardo EM; Kumar S
Cancer Res; 2009 May; 69(10):4167-74. PubMed ID: 19435897
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of the brain extracellular matrix: a new target for remyelination.
Lau LW; Cua R; Keough MB; Haylock-Jacobs S; Yong VW
Nat Rev Neurosci; 2013 Oct; 14(10):722-9. PubMed ID: 23985834
[TBL] [Abstract][Full Text] [Related]
19. The pathobiology of collagens in glioma.
Payne LS; Huang PH
Mol Cancer Res; 2013 Oct; 11(10):1129-40. PubMed ID: 23861322
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of glioma cell migration and invasion.
Demuth T; Berens ME
J Neurooncol; 2004 Nov; 70(2):217-28. PubMed ID: 15674479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
